Press Releases Novo Nordisk A/S Börse Stuttgart

Equities

NOVA

US6701002056

Market Closed - Börse Stuttgart Other stock markets 16:27:00 02/07/2024 BST			5-day change	1st Jan Change
133 ^EUR	-2.21%		+3.03%	+45.92%

07-02	Tesla, megacaps drive S&P 500, Nasdaq higher; rates outlook in focus	RE
07-02	Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say	MT

Press Releases

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Novo Holdings invests in MATR Foods expansion within plant-based fungi food	07-02	AQ
Novo Nordisk A/S - share repurchase programme	07-01	GL
Novo Nordisk stops the ocedurenone CLARION-CKD trial and recognises impairment loss	06-26	GL
New US fill finish facility receives $4.1 billion investment	06-26	AQ
Dewpoint Therapeutics Strengthens Collaboration with Novo Nordisk to Accelerate Drug Discovery	06-26	AQ
Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity adline	06-24	GL
Novo Nordisk A/S - share repurchase programme	06-24	GL
Blaze at Danish drugmaker Novo Nordisk is the third in a little over a month	06-18	AQ
Novo Nordisk announces presentation of data from key semaglutide clinical trials in diabetes, obesity and chronic kidney disease at the 84th Scientific Sessions of the American Diabetes Association	06-18	GL
World's first weekly insulin injection coming to Canada in 2 weeks, manufacturer says	06-17	AQ
Novo Nordisk A/S - share repurchase programme	06-17	GL
Haemophilia drug could reduce treated bleeding episodes	06-13	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development (CRDL,JAZZ, NVO, AZN, SNY)	06-11	AQ
Surging Biotech M&A Reaffirms Massive Opportunity In Rare Disease Drug Development	06-11	AQ
Novo Nordisk A/S - share repurchase programme	06-10	GL
Silo Pharma's (NASDAQ: SILO) Promising Developments and Key Insights for Traders and Investors	06-04	AQ
Novo Nordisk A/S - share repurchase programme	06-03	GL
NanoViricides (NNVC) Strengthens Drug Development Efforts with Calvert Labs Partnership and Announces Promising RSV Study Results	05-29	AQ
Novo Nordisk A/S - share repurchase programme	05-27	GL
MAIA Biotechnology (NYSE: MAIA) Makes Strategic Moves: Key Presentations, New Funding, and Leadership Changes Drive Innovation	05-21	AQ